Lab Automation Market Share, Size, Trends, Industry Analysis Report, By Product (Software, System); By Automation; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
The global lab automation market size is expected to reach USD 14.09 billion by 2032, according to a new study by Polaris Market Research. The report “Lab Automation Guides Market Share, Size, Trends, Industry Analysis Report, By Product (Software, System); By Automation; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Total laboratory automation (TLA) represents an innovative approach to laboratory testing, where a majority of procedures are mechanized with minimal human involvement. This approach employs software and automated equipment to handle all aspects, from pre-test planning to post-test processes, resulting in efficient routine testing, cost savings, and optimal staff utilization.
The integration of automated systems in laboratories is driven by technological advancements and the mounting pressure to deliver results. The increasing adoption of automated systems is attributed to their precision, reduced repetition, enhanced data management capabilities, and diminished human intervention, ultimately boosting both throughput and accuracy.
Laboratories hold a pivotal role across various industries, catering to manufacturing and scientific research organizations. Research and diagnostic labs are primarily aimed at providing high-quality and dependable information to meet industry requirements. The reliance on manual systems can compromise data quality during the transfer process.
Laboratory automation encompasses computerized lab instruments and devices, offering numerous benefits, such as increased productivity, reduced turnaround times, expanded workflow capabilities, and improved data quality. Furthermore, lab automation plays a crucial role in efficiently handling large volumes of sample tests within shorter timeframes.
Furthermore, the imperative to address a reduced workforce of medical technicians, cost-cutting initiatives, the growing demand for diagnostic services due to an aging technician population, and evolving testing requisites compel hospitals and clinical laboratories to embrace automation solutions.
With user expectations now centered on immersive experiences intertwined with the Internet of Things (IoT), industries have become more reliant on automation than ever before. The widespread penetration of the Internet of Things (IoT) has facilitated wireless connectivity for a wide range of applications, including access control, climate control, lighting, sample collection and analysis, and security surveillance. Additionally, robotics is being employed for tasks like restocking shelves in healthcare facilities within the medical sector, and life-saving medical equipment is interconnected, while the manufacturing sector is linking heavy machinery. These applications are anticipated to propel the examined market in the foreseeable future.
Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective Lab Automation devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for Lab Automations throughout the forecast period.
Lab Automation Market Report Highlights
In 2022, the System segment secured the most significant share of revenue. The Systems segment is a key player in the market, with an anticipated robust CAGR throughout the forecast period. Lab automation systems cover various phases of the product life cycle. Remarkably, microplate readers are currently in their initial adoption phase, suggesting that their market development is still in its infancy. The incorporation of automated robots in liquid handling segments is aimed at providing support to human operators.
The Drug Discovery segment represented the largest market share throughout the forecast period. This segment maintains its dominance in the market throughout the forecast period. Drug discovery laboratories have the ability to significantly streamline the process of designing, synthesizing, and screening compounds, condensing what would typically take weeks to just days, despite the inherent complexity and time-intensive nature of the process. This complexity is a major factor contributing to the limited participation of individuals in the drug discovery process.
The Subtotal Automation segment held the leading market share throughout the forecast period. This segment, which primarily focuses on partial automation, claims the largest share of the market during the forecast period. Laboratory processes are commonly categorized into preanalytical, analytical, and post-analytical stages. When one or two of these stages undergo automation, it falls within the domain of partial automation. These are typically autonomous specimen processing systems designed to execute various tasks. Partial automation presents a cost-effective alternative compared to comprehensive laboratory automation setups.
In 2022, North America took the lead in the market.Throughout the forecast period, North America establishes itself as a prominent force in the global lab automation market. Initially, the United States embraced a successful lab automation strategy, following Japan's lead. Numerous hospitals undertook lab automation initiatives to tackle personnel shortages, improve the accuracy of diagnostic results, and enhance patient care. Traditional device-based diagnostic methods were more costly for insurance providers, leading some to reduce reimbursements over the last decade.
The global key market players include Abbott, Agilent Technologies, Bio-Rad Laboratories, CrelioHealth, Danaher, Dassault Systèmes, Hoffmann-La Roche, Illumia, INTEGRA Biosciences, LabLynx, LabVantage, Peak Analysis & Automation, Siemens Healthineers, Tecan, Thermo Fisher Scientific.
Polaris Market Research has segmented the Lab Automation market report based on product, automation, application, end-user and region:
Lab Automation, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Software
System
Lab Automation, Automation Outlook (Revenue - USD Billion, 2019 - 2032)
Task Targeted Automation
Total Laboratory Automation
Subtotal Automation
Lab Automation, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Genomics Solutions
Microbiology
Drug Discovery
Clinical Diagnostics
Others
Lab Automation, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospitals and Diagnostic Laboratories
Forensic Laboratories
Environmental Testing Laboratories
Food and Beverages
Research and Academic Institutes
Biotechnology and Pharma Companies
Lab Automation, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa